| __timestamp | Pharming Group N.V. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4167274 | 22622695 |
| Thursday, January 1, 2015 | 5247851 | 24863028 |
| Friday, January 1, 2016 | 4925118 | 21351001 |
| Sunday, January 1, 2017 | 14930297 | 53837297 |
| Monday, January 1, 2018 | 25371768 | 16080096 |
| Tuesday, January 1, 2019 | 23921274 | 18525736 |
| Wednesday, January 1, 2020 | 25338236 | 2024000 |
| Friday, January 1, 2021 | 20182966 | 2548000 |
| Saturday, January 1, 2022 | 17562000 | 61556000 |
| Sunday, January 1, 2023 | 25212000 | 188157000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Pharming Group N.V. and Telix Pharmaceuticals Limited have shown distinct trends in their cost of revenue. Pharming Group N.V. experienced a steady increase, peaking in 2018 with a 510% rise from 2014. Meanwhile, Telix Pharmaceuticals Limited saw a dramatic surge, especially in 2023, with costs skyrocketing by over 730% compared to 2014. This divergence highlights differing strategic approaches: Pharming's consistent growth versus Telix's aggressive expansion. Such insights are vital for investors and stakeholders aiming to navigate the complexities of the pharmaceutical market. As the industry continues to innovate, monitoring these financial metrics will be key to understanding future trajectories.
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Telix Pharmaceuticals Limited's Expenses
United Therapeutics Corporation vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Pharming Group N.V.
Cost of Revenue Trends: Pharming Group N.V. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Dyne Therapeutics, Inc.'s Expenses
Pharming Group N.V. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Alkermes plc
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Perrigo Company plc's Expenses